Huazheng Pan

No. 16, Jiangsu Road
Qingdao, 266003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

The key pathways and genes related to oncolytic Newcastle disease virus-induced phenotypic changes in ovarian cancer cells.

The key pathways and genes related to oncolytic Newcastle disease virus-induced phenotypic changes in ovarian cancer cells.

Journal: Journal of microbiology (Seoul, Korea)

Published: November 12, 2024

Mutations in the NDV fusion protein HR4 region decreased fusogenic activity due to failed protein expression.

Mutations in the NDV fusion protein HR4 region decreased fusogenic activity due to failed protein expression.

Journal: Microbial pathogenesis

Published: January 03, 2024

Characterization of a novel genus of jumbo phages and their application in wastewater treatment.

Characterization of a novel genus of jumbo phages and their application in wastewater treatment.

Journal: iScience

Published: November 09, 2022

Lestaurtinib Has the Potential to Inhibit the Proliferation of Hepatocellular Carcinoma Uncovered by Bioinformatics Analysis and Pharmacological Experiments.

Lestaurtinib Has the Potential to Inhibit the Proliferation of Hepatocellular Carcinoma Uncovered by Bioinformatics Analysis and Pharmacological Experiments.

Journal: Frontiers in cell and developmental biology

Published: December 16, 2021

Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma.

Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma.

Journal: International journal of medical sciences

Published: December 01, 2021

Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.

Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.

Journal: Aging

Published: October 25, 2021

TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3.

TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3.

Journal: Cancer cell international

Published: June 29, 2020

TUG1 long non-coding RNA enlists the USF1 transcription factor to overexpress ROMO1 leading to hepatocellular carcinoma growth and metastasis.

TUG1 long non-coding RNA enlists the USF1 transcription factor to overexpress ROMO1 leading to hepatocellular carcinoma growth and metastasis.

Journal: MedComm

Published: June 17, 2020

Dermatopontin inhibits WNT signaling pathway via CXXC finger protein 4 in hepatocellular carcinoma.

Dermatopontin inhibits WNT signaling pathway via CXXC finger protein 4 in hepatocellular carcinoma.

Journal: Journal of Cancer

Published: April 18, 2020

LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.

LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.

Journal: Molecular and cellular biochemistry

Published: March 19, 2020

Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis.

Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 16, 2019

LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression.

LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression.

Journal: Journal of Cancer

Published: December 17, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026